UGT

UGT製品

  • All (8)
  • UGT阻害剤 (3)
  • UGT活性剤(1)
  • UGT作動薬(1)
  • 新製品
製品コード 製品名称 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S4067 Deferiprone Deferiprone (CP20) is a chelating agent with an affinity for ferric ion (iron III),binds with ferric ions to form neutral 3:1 (deferiprone:iron) complexes that are stable over a wide range of pH values.
Redox Biol, 2025, 85:103739
bioRxiv, 2025, 2025.07.10.663832
Cancer Lett, 2024, 592:216898
S2487 Mycophenolic acid Mycophenolic acid (Mycophenolate, RS-61443) is a potent IMPDH inhibitor and the active metabolite of an immunosuppressive drug, used to prevent rejection in organ transplantation.
EMBO Mol Med, 2025, 10.1038/s44321-025-00278-4
Cancer Cell, 2023, 41(1):124-138.e6
Cells, 2023, 12(5)743
S7828 Licochalcone A Licochalcone A is an estrogenic flavanoid extracted from licorice root, showing antimalarial, anticancer, antibacterial and antiviral activities. Phase 3.
Br J Pharmacol, 2023, 180(8):1114-1131
Eur J Pharmacol, 2023, 957:176031
Front Oncol, 2022, 12:1006131
S3608 Demethylzeylasteral (T-96) Demethylzeylasteral (T-96), the active component isolated from Tripterygium wilfordii Hook F., inhibits UDP-glucuronosyltransferase (UGT) isoforms UGT1A6 and UGT2B7 with immunosuppressive effects.
J Cancer, 2025, 16(1):227-240
J Cancer, 2021, 12(13):3967-3975
Front Biosci (Landmark Ed), 2020, 25:498-512
S3018 Niflumic acid Niflumic acid is an inhibitor of cyclooxygenase-2 used for joint and muscular pain.
Oncol Lett, 2020, 20(4):39
S6828 Cremophor EL Cremophor EL, a polyethoxylated surfactant, is a formulation vehicle used for various poorly-water soluble drugs, including the anticancer agent paclitaxel (Taxol). Cremophor EL is used in severe anaphylactoid hypersensitivity reactions, hyperlipidaemia, abnormal lipoprotein patterns, aggregation of erythrocytes and peripheral neuropathy.
Aging Dis, 2024, 16(2):1120-1140
Front Oncol, 2022, 12:936145
S0931 Jaceosidin Jaceosidin, a flavonoid isolated from Artemisia vestita, possesses anti-tumor and anti-proliferative activities in many cancer cells. Jaceosidin induces apoptosis, activates Bax and down-regulates Mcl-1 and c-FLIP expression. Jaceosidin inhibits COX-2 expression and NF-κB activation.
S7828 Licochalcone A Licochalcone A is an estrogenic flavanoid extracted from licorice root, showing antimalarial, anticancer, antibacterial and antiviral activities. Phase 3.
Br J Pharmacol, 2023, 180(8):1114-1131
Eur J Pharmacol, 2023, 957:176031
Front Oncol, 2022, 12:1006131
S2487 Mycophenolic acid Mycophenolic acid (Mycophenolate, RS-61443) is a potent IMPDH inhibitor and the active metabolite of an immunosuppressive drug, used to prevent rejection in organ transplantation.
EMBO Mol Med, 2025, 10.1038/s44321-025-00278-4
Cancer Cell, 2023, 41(1):124-138.e6
Cells, 2023, 12(5)743
S3608 Demethylzeylasteral (T-96) Demethylzeylasteral (T-96), the active component isolated from Tripterygium wilfordii Hook F., inhibits UDP-glucuronosyltransferase (UGT) isoforms UGT1A6 and UGT2B7 with immunosuppressive effects.
J Cancer, 2025, 16(1):227-240
J Cancer, 2021, 12(13):3967-3975
Front Biosci (Landmark Ed), 2020, 25:498-512
S3018 Niflumic acid Niflumic acid is an inhibitor of cyclooxygenase-2 used for joint and muscular pain.
Oncol Lett, 2020, 20(4):39
S0931 Jaceosidin Jaceosidin, a flavonoid isolated from Artemisia vestita, possesses anti-tumor and anti-proliferative activities in many cancer cells. Jaceosidin induces apoptosis, activates Bax and down-regulates Mcl-1 and c-FLIP expression. Jaceosidin inhibits COX-2 expression and NF-κB activation.
S7828 Licochalcone A Licochalcone A is an estrogenic flavanoid extracted from licorice root, showing antimalarial, anticancer, antibacterial and antiviral activities. Phase 3.
Br J Pharmacol, 2023, 180(8):1114-1131
Eur J Pharmacol, 2023, 957:176031
Front Oncol, 2022, 12:1006131